CD4 and plasma cell myeloma: Our previous studies have shown that DCs generated from peripheral blood mononuclear cells of multiple myeloma patients and loaded with glycoengineered multiple myeloma antigens evoked strong allogeneic stimulatory activity in mixed lymphocyte reactions and efficiently activated CD4+ and CD8+ T cells.